Issued Patents All Time
Showing 25 most recent of 29 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 8748577 | Conjugates of biologically active polypeptides having an increased in vivo half-life | Marc Besman, Stewart Chipman, David Leung | 2014-06-10 |
| 8129348 | Conjugates of biologically active proteins having a modified in vivo half-life | Marc Besman, Stewart Chipman, David Leung | 2012-03-06 |
| 7173041 | Polyglutamic acid-camptothecin conjugates and methods of preparation | Rama Bhatt, Peter Vries, J. Peter Klein, John Tulinsky, Robert Lewis | 2007-02-06 |
| 7153864 | Polyglutamic acid-camptothecin conjugates and methods of preparation | Rama Bhatt, Peter Vries, J. Peter Klein, John Tulinsky, Robert Lewis | 2006-12-26 |
| 6638938 | Method for preventing tissue injury from hypoxia | Stuart L. Bursten, Glenn C. Rice | 2003-10-28 |
| 6420374 | Use of xanthines as immunosuppressants and to inhibit allograft reactions | James A. Bianco, William J. Novick, Jr. | 2002-07-16 |
| 6057328 | Method for treating hyperoxia | Edward Abraham | 2000-05-02 |
| 5985926 | Method for inhibiting intracellular viral replication | David Leung, Gail E. Underiner | 1999-11-16 |
| 5965564 | Enantiomerically pure hydroxylated xanthine compounds | James A. Bianco, Paul Woodson, David Porubek | 1999-10-12 |
| 5929081 | Method for treating diseases mediated by cellular proliferation in response to PDGF, EGF, FGF and VEGF | Paul A. Brown, Stuart L. Bursten, Glenn C. Rice | 1999-07-27 |
| 5859017 | Method for inhibiting mast cell and basophil activation | Elisa Eiseman, Emer Clarke, Stuart L. Bursten | 1999-01-12 |
| 5859018 | Method for treating diseases mediated by cellular proliferation in response to PDGF, EGF, FGF, and VEGF | Paul A. Brown, Stuart L. Bursten, Glenn C. Rice | 1999-01-12 |
| 5856331 | Method for preventing tissue injury from hypoxia | Stuart L. Bursten, Glenn C. Rice | 1999-01-05 |
| 5856115 | Assay for identification therapeutic agents | James A. Bianco, Stuart L. Bursten | 1999-01-05 |
| 5795898 | Method for treating diseases mediated by cellular proliferation in response to PDGF,EGF,FGF and VEGF | Paul A. Brown, Stuart L. Bursten, Glenn C. Rice | 1998-08-18 |
| 5792772 | Enatiomerically pure hydroxylated xanthine compounds | James A. Bianco, Paul Woodson, David Porubek | 1998-08-11 |
| 5739138 | Enantiomerically pure hydroxylated xanthine compounds to treat autoimmune diabetes | James A. Bianco, Paul Woodson, David Porubek | 1998-04-14 |
| 5670507 | Method for reversing multiple drug resistant phenotype | Glenn C. Rice | 1997-09-23 |
| 5652243 | Methods of using enantiomerically pure hydroxylated xanthine compounds | James A. Bianco | 1997-07-29 |
| 5648357 | Enatiomerically pure hydroxylated xanthine compounds | James A. Bianco, Paul Woodson, David Porubek | 1997-07-15 |
| 5629315 | Treatment of diseases using enantiomerically pure hydroxylated xanthine compounds | James A. Bianco, Paul Woodson, David Porubek | 1997-05-13 |
| 5620984 | Enatiomerically pure hydroxylated xanthine compounds to treat inflammatory diseases | James A. Bianco, Paul Woodson, David Porubek | 1997-04-15 |
| 5621102 | Process for preparing enantiomerically pure xanthine derivatives | James A. Bianco, Paul Woodson, David Porubek | 1997-04-15 |
| 5612349 | Enantiomerically pure hydroxylated xanthine compounds to treat shock symptoms | James A. Bianco, Paul Woodson, David Porubek | 1997-03-18 |
| 5585380 | Modulation of cellular response to external stimuli | James A. Bianco, Stuart L. Bursten | 1996-12-17 |